KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $348,812 | +9.1% | 3,007 | +10.4% | 0.00% | 0.0% |
Q2 2023 | $319,798 | +14.9% | 2,724 | -21.6% | 0.00% | 0.0% |
Q1 2023 | $278,289 | +8.1% | 3,476 | +7.0% | 0.00% | 0.0% |
Q4 2022 | $257,418 | -16.7% | 3,249 | -26.6% | 0.00% | 0.0% |
Q3 2022 | $309,000 | +8.0% | 4,428 | +1.7% | 0.00% | 0.0% |
Q2 2022 | $286,000 | -30.8% | 4,356 | -29.8% | 0.00% | -50.0% |
Q1 2022 | $413,000 | -3.3% | 6,201 | +4.8% | 0.00% | 0.0% |
Q4 2021 | $427,000 | +72.9% | 5,916 | +25.1% | 0.00% | +100.0% |
Q3 2021 | $247,000 | -21.1% | 4,730 | +2.8% | 0.00% | -50.0% |
Q2 2021 | $313,000 | -52.6% | 4,601 | -46.3% | 0.00% | -50.0% |
Q1 2021 | $660,000 | +89.7% | 8,572 | +47.6% | 0.00% | +33.3% |
Q4 2020 | $348,000 | +126.0% | 5,808 | +62.0% | 0.00% | +200.0% |
Q3 2020 | $154,000 | +4.1% | 3,586 | +0.3% | 0.00% | -50.0% |
Q2 2020 | $148,000 | +2.8% | 3,575 | +7.2% | 0.00% | 0.0% |
Q1 2020 | $144,000 | -8.3% | 3,334 | +26.3% | 0.00% | 0.0% |
Q4 2019 | $157,000 | – | 2,639 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |